According to the latest report by IMARC Group, titled “Positive Airway Pressure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global positive airway pressure devices market size reached US$ 3.4 Billion in 2022. Positive airway pressure (PAP) device refers to medical equipment utilized for treating sleep-related breathing disorders. They consist of several components, such as a nasal pillow mask, tubing, filters, and a machine that pumps a stream of pressurized air. PAP devices are widely used to treat obstructive sleep apnea (OSA), snoring, respiratory failure, chronic obstructive pulmonary disease (COPD), neuromuscular disorders, and congestive heart failure. They are highly effective and non-invasive devices that improve sleep quality, prevent breathing interruption, minimize health complications, and reduce daytime sleepiness. PAP devices also improve mood, increase cognitive functions, minimize sleep deprivation, and enhance the quality of life.
Positive Airway Pressure Devices Market Trends:
The increasing prevalence of OSA due to hypertension, obesity, depression, and heart-related disorders is one of the primary factors driving the market growth. PAP devices are widely used to treat OSA by continuously delivering pressurized air to the lungs during sleep, keeping airways open, and preventing the collapse of soft tissue, which minimizes breathing interruption and improves sleep quality. In addition to this, the rising geriatric population with high susceptibility to sleep-related breathing disorders is acting as another growth-inducing factor. Furthermore, the increasing demand for portable and wearable products that are comfortable, travel-friendly, easy to use, and enhance user convenience is providing an impetus to the market growth. Additionally, the introduction of advanced PAP devices equipped with data tracking and analytics capabilities that allow healthcare professionals to monitor patients therapy and adjust treatment accordingly is positively influencing the market growth. Moreover, increasing awareness among the masses regarding the risks and complications associated with sleep-related breathing disorders is creating a positive outlook for the market. Other factors, including the implementation of favorable government policies to improve patient access to various PAP devices, increasing investment in the research and development (R&D) of innovative products, significant growth in the healthcare industry, and rising demand for home-based PAP therapy, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 4.9 Billion by 2028, exhibiting a CAGR of 6% during 2023-2028.
- On the basis of product type, the market has been divided into automatic positive airway pressure (APAP), continuous positive airway pressure (CPAP), and bi-level positive airway pressure (BiPAP) devices.
- Based on the end user, the market has been classified into hospitals and sleep labs, home care, and others.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
- The competitive landscape of the industry has also been examined, with some of the key players being 3B Medical Inc., Apex Medical Corp., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Drive Devilbiss Healthcare (Drive International LLC), Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Resmed Inc., Smiths Group Plc, Somnetics International Inc. and Vyaire Medical Inc.
|Base Year of the Analysis
||Product Type, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3B Medical Inc., Apex Medical Corp., Compumedics Limited (D & DJ Burton Holdings Pty Ltd.), Drive Devilbiss Healthcare (Drive International LLC), Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Resmed Inc., Smiths Group Plc, Somnetics International Inc. and Vyaire Medical Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800